Improving the removal of toxic substances in the blood by two different forms of peritoneal dialysis (a treatment for patients with chronic kidney disease with intraabdominal fluid exchange to remove fluid and toxic substances from the blood whereby the peritoneal membrane serves as a filter).
Phase 1
- Conditions
- Chronic kidney disease G5DTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02]
- Registration Number
- EUCTR2016-004176-22-AT
- Lead Sponsor
- Medizinische Universität Graz
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 22
Inclusion Criteria
•Male and female probands aged between 18 – 85 years
•Written consent of the participant after being informed
•PD treatment for at least 3 months
•Stable on PD for at least 3 months
•Peritonitis-free for at least 3 months
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 11
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 11
Exclusion Criteria
•Known intolerance/hypersensitivity against balance Peritonealdialyselösungen”
•Purification parameters known to be below K/DOQI recommended value of a minimum total Kt/Vurea of 1.7
•Current involvement in another clinical trial
•Pregnancy or breast-feeding
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method